On March 18, 2021, the board of directors of MedTech Acquisition Corporation appointed Thierry Thaure as a director of the Company. Mr. Thaure has over 35 years of experience in medical device technology as an entrepreneur, senior executive and director. Since 2019, Mr. Thaure has been Chief Executive Officer and a Director of Triflo Cariovascular Inc. From 2012 to 2019, he was co-Founder and Chief Executive Officer of Cephea Valve Technologies Inc., a company that developed a percutaneous mitral valve replacement technology and was purchased by Abbott Laboratories in 2019.